Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Non-cash Items (2020 - 2025)

Historic Non-cash Items for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $4.8 million.

  • Pulse Biosciences' Non-cash Items rose 1503.05% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 1503.05%. This contributed to the annual value of $4.5 million for FY2024, which is 1805.8% up from last year.
  • According to the latest figures from Q3 2025, Pulse Biosciences' Non-cash Items is $4.8 million, which was up 1503.05% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, Pulse Biosciences' Non-cash Items registered a high of $15.8 million during Q4 2021, and its lowest value of $2.9 million during Q1 2021.
  • Moreover, its 5-year median value for Non-cash Items was $3.7 million (2022), whereas its average is $4.5 million.
  • As far as peak fluctuations go, Pulse Biosciences' Non-cash Items soared by 51906.65% in 2021, and later crashed by 7797.77% in 2022.
  • Quarter analysis of 5 years shows Pulse Biosciences' Non-cash Items stood at $15.8 million in 2021, then plummeted by 77.98% to $3.5 million in 2022, then rose by 10.18% to $3.8 million in 2023, then grew by 18.06% to $4.5 million in 2024, then rose by 6.19% to $4.8 million in 2025.
  • Its Non-cash Items stands at $4.8 million for Q3 2025, versus $5.0 million for Q2 2025 and $4.7 million for Q1 2025.